Beximco Pharma receives GMP approval from Health Canada
Bangladeshi pdrugmaker Beximco Pharma has received Good Manufacturing Practices (GMP) approval from Health Canada, the Canadian regulatory body, making it the first pharma company in Bangladesh to receive such accreditation.
This opens the company up to marketing its drugs in Canada, which is increasingly promoting access to generic drugs produced by companies such as Beximco. Taiwan also granted GMP approval to Beximco this year.
Nazmul Hassan, managing director of Beximco Pharma, said: “Canada is an important market for Beximco Pharma and this approval marks a significant milestone for the company, further validating our high standards of quality and compliance practices. This approval builds on our existing presence in key regulated markets and is an important step towards our aspiration to become a global generic drug player.’’
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
More Features in Generics
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze